Tech Company Financing Transactions
Abide Therapeutics Funding Round
Cardinal Partners and private investors joined a $4.5 million capital raise for Abide Therapeutics. The round was announced on 6/30/2012.
Transaction Overview
Company Name
Announced On
6/30/2012
Transaction Type
Venture Equity
Amount
$4,500,000
Round
Undisclosed
Investors
Cardinal Partners (John Clarke)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
10835 Road to the Cure 250
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Realizing the therapeutic potential of novel serine hydrolase inhibitors to yield drugs for treatment of diseases in areas of unmet medical need.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Alan Ezekowitz
Chief Financial Officer
Stan Blackburn
Chief Financial Officer
Sapna Srivastava
Chief Medical Officer
Chan Beals
VP - Operations
Julianne Hunt
VP - R & D
Gary O'Neill
Browse more venture capital transactions:
Prev: 6/30/2012: UICO venture capital transaction
Next: 6/30/2012: X-Factor Communications venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on tech company VC transactions. VC transactions on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs